Gordon Keller, recipient of the 2019 Ogawa-Yamanaka Stem Cell Prize, discusses challenges and successes during his 30 years of pioneering research on stem cells.
These tiny versions of the heart, brain, intestine, lungs, and other organs are transforming how we research human disease and development at Gladstone and beyond.
NIH award supports collaborative work to discover the connection between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.
Gladstone Institutes and Xyphos Biosciences have shown that a cell-based immunotherapy, convertibleCAR®, can reduce the latent reservoir of virus in HIV-infected patients on anti-retroviral therapy
September 16–September 20, 2019, was the 10th Annual National Postdoc Appreciation Week!
On National Coming Out Day, four scientists at Gladstone explain what the day means to them and why it’s important to create an open and inclusive environment.
Since Shinya Yamanaka discovered a method to create human induced pluripotent stem cells (hiPS cells), Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.
Each year, Gladstone welcomes the incoming class of UCSF students to tour the facilities and meet Gladstone investigators.
Gladstone Senior Investigator Warner C. Greene, MD, PhD, director of the Gladstone Center for HIV Cure Research, receives this year’s Lifetime Achievement Award for Scientific Contributions from the University of Maryland School of Medicine’s Institute of Human Virology. The award recognizes Greene’s over 30 years of research in virology and HIV/AIDS pathology.